Vapreotide is a somatostatin analog with a higher metabolic stability than the parent hormone. Vapreotide reduces splanchnic blood flow, inhibits growth hormone release, and inhibits the release of peptides and vasoactive compounds from neuroendocrine tumors.
CAT No:10-101-44
CAS No:103222-11-3 (net), 116430-60-5 (acetate) 849479-74-9(ChemIDplus)
Synonyms/Alias:RC-160; Octastatin; RC 160; RC160; Vapreotida; DB04894
Quick InquiryPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C59H74N12O11S2 |
M.W/Mr. | 1191.44 |
Sequence | Three Letter Code: D-Phe-Cys-Trp-D-Trp-Lys-Val-Cys-Trp-CONH2(disulfide Cys2-Cys7) |
Application | Vapreotide is a synthetic octapeptide somatostatin analog with a different receptor affinity to octreotide. It is used for the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea. |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.